Research at Oslo University Hospital
More than 50 per cent of the total medical research in Norwegian medical centres is performed at Oslo University Hospital. This is the result of the hospital’s general research strategy and its extensive international and national network cooperation.
In this way, the medical centre complies with the requirements of its owner and patients relating to its role as national reference hospital, responsible for introducing and developing new medical examination methods, treatment methods and follow-ups. Research that supports prioritised areas of commitment will also safeguard the operation and development of national and multi-regional assignments, as well as the functions of the medical resource centres.
Latest news
NBS prizes to PhD students from Institute for Cancer Research
Two PhD students at the Dept. of Biochemistry and CCB at the Institute for Cancer Research, Simona Kavaliauskiene (Sandvig’s group) working with membrane transport, and Angela Oppelt (Wiedlocha’s group) studying cell movement, were honored by a poster-prize and a prize for an excellent lecture, respectively.
Institute seminars spring season 2012
The upcoming seminar on Wednesday January 25th will be held by Pierre Åman from Cancercentrum, Sahlgrenska Hospital, Göteborg, Sweden (invited by Ola Myklebost, Dept. of Tumor Biology).
The institute seminars are held in the new research building at Montebello (photo) on Wednesdays from 12-13.
Aiming at national support for targeted cancer therapy research
Oslo Cancer Cluster recently arranged their annual "Cancer Crosslinks Seminar". This year the subject was targeted cancer therapy. Among the lecturers was professor Ola Myklebost, senior researcher at the Department of Tumor Biology and leader of The Norwegian Cancer Genomics Consortium (NCGC).
2011 was the starting year for a governmental research programme for clinical cancer studies, administered by the Norwegian Research Council. The theme area for the announcement is "individually adapted cancer treatment". A sum amounting to 100 mill NOK will be distributed over a period of 5 years and 60 mill NOK was announced this autumn. The NCGS has applied for support for a research project spanning 3 years for studying genetic changes in tumors.
Christos Samakovlis: The molecular basis of airway maturation in Drosophila
Jan 17, 2012
Selected latest publications
Journ. Impact factor > 8 First or last author from Oslo University Hospital
Hospitalisations and surgery in Crohn's disease
Gut (in press)
PubMed 22267595
Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction results from the norwegian heart failure registry
J Am Coll Cardiol, 59 (4), 371-8
PubMed 22261159
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
Gut (in press)
PubMed 22213796
More selected publications









